MyFinsight
Home
About
Contact
cue: the income statement
Download
Download image
Comprehensive loss
-$7,447K
(14.01%↑ Y/Y)
Unrealized gain from
available-for-sale securities
$1K
Interest income
$222K
(-35.28%↓ Y/Y)
Net loss
-$7,448K
(14.00%↑ Y/Y)
Total other income,
net
$147K
(-5.16%↓ Y/Y)
Interest expense
-$75K
(60.11%↑ Y/Y)
Loss from operations
-$7,595K
(13.84%↑ Y/Y)
Collaboration revenue
$2,149K
(-35.58%↓ Y/Y)
Total operating
expenses
$9,744K
(-19.81%↓ Y/Y)
Loss (gain) on fixed
asset disposal
-$51K
Research and development
$4,754K
(-49.32%↓ Y/Y)
General and
administrative
$4,939K
(72.27%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Cue Biopharma, Inc. (CUE)
Cue Biopharma, Inc. (CUE)